Ågmo A, Fernandez H (1991) Benzodiazepine receptor ligands and sexual behavior in the male rat: the role of GABAergic mechanisms. Pharmacol Biochem Behav 38:781–788

Ågmo A, Tarasco C (1985) Interactions between naloxone and GABA in the control of locomotor activity in the rat. J Neural Transm 61:137–149

Ågmo A, Paredes R, Fernandez H (1987) Differential effects of GABA transaminase inhibitors on sexual behavior, locomotor activity, and motor execution. Pharmacol Biochem Behav 28:47–52

Ågmo A, Pruneda R, Guzman M, Gutiérrez M (1991) GABAergic drugs and conflict behavior in the rat: lack of similarities with the actions of benzodiazepines. Naunyn-Schmiedeberg's Arch Pharmacol 344:314–322

Ågmo A, Rojas J, Vazquez P (1992) The inhibitory effects of opiates on male rat sexual behavior may be mediated by opiate receptors outside the central nervous system. Psychopharmacology 107:89–96

Billingsley ML, Kubena RK (1978) The effects of naloxone and picrotoxin on the sedative and anticonflict effects of benzodiazepines. Life Sci 22:897–906

Brady KT, Lydiard RB, Ballenger JC, Shook J, Laraia M, Fossey M (1991) CSF opioids in panic disorder. Biol Psychiatry 30:512–514

Britton DR, Britton KT, Dalton D, Vale W (1981) Effects of naloxone on anticonflict and hyperphagic actions of diazepam. Life Sci 29:1297–1302

Brown BS, Chaitkin L (1981) Use of stimulant/depressant drugs by drug abuse clients in selected metropolitan areas. Int J Addict 16:1473–1490

Brown DR, Robertson MJ, Goldberg LI (1983) Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives. Neuropharmacology 22:317–321

Cannizaro G, Flugy A, Novara V, Provenzano PM (1987) Interaction between naloxone, chlordiazepoxide and valproic acid evaluated by emotional operant behaviour in the rat. Arzneimittelforschung 37:6–9

Carlsson KR, Seeger TF (1982) Interaction of opiates with dopamine receptors: receptor binding and behavioral assays. Pharmacol Biochem Behav 16:119–124

Cohen GA, Doze VA, Madison DV (1992) Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal neurons. Neuron 9:325–333

Cooper SJ (1983) Benzodiazepine-opiate antagonist interactions in relation to feeding and drinking behavior. Life Sci 32:1043–1051

Cooper SJ, McGivern H (1983) Effects of naloxone and naltrexone on the increased water intake and drinking duration in phenobarbitone-treated rats. Psychopharmacology 79:25–28

Darke S, Swift W, Hall W, Ross M (1993) Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients. Drug Alcohol Depend 34:67–70

Dingledine R, Iversen LL, Breuker E (1978) Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies. Eur J Pharmacol 47:19–27

Doble A, Martin IL (1992) Multiple benzodiazepine receptors: no reason for anxiety. Trends Pharmacol Sci 13:76–81

Donzanti BA, Althaus JS, Payson MM, Von Voigtlander PF (1992) Kappa agonist-induced reductions in dopamine release: site of action and tolerance. Res Commun Chem Pathol Pharmacol 78:193–210

Duka T, Wüster M, Herz A (1979) Rapid changes in enkephalin levels in rat striatum and hypothalamus induced by diazepam. Naunyn-Schmiedeberg's Arch Pharmacol 309:1–5

Duka T, Wüster M, Herz A (1980) Benzodiazepines modulate striatal enkephalin levels via a GABAergic mechanism. Life Sci 26:771–776

Duka T, Cumin R, Haefely W, Herz A (1981) Naloxone blocks the effect of diazepam and meprobamate on conflict behaviour in rats. Pharmacol Biochem Behav 15:115–117

File SE (1982) Chlordiazepoxide-induced ataxia, muscle relaxation and sedation in the rat: effects of muscimol, picrotoxin and naloxone. Pharmacol Biochem Behav 17:1165–1170

Forman LJ, Estilow-Isabell S, Harwell M, de Salvo S, Cater J (1991) Possible opiate action in the anxiolytic and antinociceptive actions of alprazolam. Res Commun Chem Pathol Pharmacol 71:259–271

Friedman SB, Adler R, Grota LJ, Larson T (1967) Plasma corticosterone response to parameters of electric shock in rats. Psychosom Med 29:323–328

Gardner CR (1988) Potential use of drugs modulating 5-HT activity in the treatment of anxiety. Gen Pharmacol 19:347–356

Gilbert PE, Martin WR (1977) Antagonism of the effects of pentobarbital in the chronic spinal dog by naloxone. Life Sci 20:1401–1406

Giusti P, Arban R (1993) Physiological and pharmacological bases for the diverse properties of benzodiazepines and their congeners. Pharmacol Res 27:201–215

Goldinger A, Müller WE, Wollert U (1981) Inhibition of glycine and GABA receptor binding by several opiate agonists and antagonists. Gen Pharmacol 12:477–479

Goldstein A (1987) Binding selectivity profiles for ligands of multiple receptor types: focus on opioid receptors. Trends Pharmacol Sci 8:456–460

Gomar MD, Castillo JL, del Aguila C, Fernández B, Acuna-Castroviejo D (1993a) Intracerebroventricular injection of naloxone blocks melatonin-dependent brain3H-flunitrazepam binding. Neuroreport 4:987–990

Gomar MD, Fernández B, Castillo JL, del Aguila C, Acuna-Castroviejo D (1993b) Suppressive effect of simultaneous injection of ACTH 1–10 and β-endorphin on brain3H-flunitrazepam binding. Neuroreport 5:252–254

Gruen RJ, Friedhoff AJ, Coale A, Moghaddam B (1992) Tonic inhibition of striatal dopamine transmission: effects of benzodiazepine and GABA A receptor antagonists on extracellular dopamine levels. Brain Res 599:51–56

Harris JA, Westbrook RF (1994) Effects of midazolam and naloxone in rats tested for sensitivity/reactivity to formalin pain in a familiar, novel or aversively conditioned environment. Psychopharmacology 115:65–72

Harsing LG, Yang HY, Costa E (1982) Evidence for γ-aminobutyric acid (GABA) mediation in the benzodiazepine inhibition of the release of met5-enke-phalin elicited by depolarisation. J Pharmacol Exp Ther 220:616–620

Herling S (1983) Naltrexone blocks the response-latency increasing effects but not the discriminative effects of diazepam in rats. Eur J Pharmacol 88:121–124

Jacquet YF, Saederup E, Squires RF (1987) Non-stereospecific excitatory actions of morphine may be due to GABA A receptor blockade. Eur J Pharmacol 138:285–288

Johnson SW, North RA (1992) Opiods excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483–488

Kleber HD, Gold MS (1978) Use of psychotropic drugs in treatment of methadone maintained narcotic addicts. Ann NY Acad Sci 311:81–98

Koob GF, Strecker RE, Bloom FE (1980) Effects of naloxone on the anticonflict properties of alcohol and chlordiazepoxide. Subst Alcohol Actions/Misuse 1:447–457

Lerner T, Feldon J, Myslobodsky MS (1986) Amphetamine potentiation of anti-conflict action of chlordiazepoxide. Pharmacol Biochem Behav 24:241–246

Levine AS, Morley JE, Gosnell BA, Billington CJ, Bartness TJ (1985) Opioids and consummatory behavior. Brain Res Bull 14:663–672

Larsen PJ, Mau SE (1994) Effect of acute stress on the expression of the hypothalamic messenger ribonucleic acids encoding the endogenous opioid precursors preproenkephalin A and proopiomelanocortin. Peptides 15:783–790

Lopez F, Miller LG, Thompson ML, Schatzki A, Chesley S, Greenblatt DJ, Shader RI (1990) Chronic morphine administration augments benzodiazepine binding and GABA A receptor function. Psychopharmacology 101:545–549

Lorens SA, Sainati SM (1978) Naloxone blocks the excitatory effects of ethanol and chlordiazepoxide on lateral hypothalmic self-stimulation. Life Sci 23:1359–1364

Maccari S, Piazza PV, Deminière JM, Lemaire V, Mormède P, Simon H, Angelucci L, Le Moal M (1991) Life events decrease of corticosteroid type I receptors is associated with reduced vulnerability to amphetamine self-administration. Brain Res 547:7–12

Maier SF (1990) Diazepam modulation of stress-induced analgesia depends on the type of analgesia. Behav Neurosci 104:339–347

Maier SF, Ryan SM, Barksdale CM, Kalin NH (1986) Stressor controllability and the pituitary-adrenal system. Behav Neurosci 100:669–674

Manzanares J, Lookingland KJ, Moore KE (1991) Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain. J Pharmacol Exp Ther 256:500–505

Martin DC, Introna RP, Aronstam RS (1991) Fentanyl and sufentanyl inhibit agonist binding to 5-HT 1A receptors in membranes from the rat brain. Neuropharmacology 30:323–327

Millan MJ, Duka T (1981) Anxiolytic properties of opiates and endogenous opioid peptides and their relationship to the actions of benzodiazepines. Mod Probl Pharmacopsychiatry 17:123–141

Miller LG, Thompson ML, Greenblatt DJ, Deutsch SI, Shader RI, Paul SM (1987) Rapid increase in benzodiazepine binding following defeat stress in mice. Brain Res 414:395–400

Misra AL, Pontani RB, Vadlamani NL, Mulé SJ (1976) Physiological disposition and biotransformation of allyl-1′-3′-14C naloxone in the rat and some comparative observations on nalorphine. J Pharmacol Exp Ther 196:257–268

Möhler H, Okada T (1977) Benzodiazepine receptor: demonstration in the CNS. Science 198:849–851

Naruse T, Asami T, Koizumi Y (1989) Effects of naloxone and picrotoxin on diazepam- or pentobarbital-induced hyperphagia in nondeprived rats. Pharmacol Biochem Behav 31:709–711

Nicoll RA, Alger BE, Jahr CE (1980) Enkephalin blocks inhibitory pathways in the vertebrate CNS. Nature 287:22–25

Olsen RW, Leeb-Lundberg F (1981) Convulsant and anticonvulsant drug binding sites related to the GABA receptor/ionophore system. In: Morselli PL, Lloyd KG, Löscher W, Meldrum B, Reynolds EH (eds) Neurotransmitters, seizures and epilepsy. Raven, New York, pp 151–164

Olson GA, Olson RD, Kastin AJ (1993) Endogenous opioids: 1992. Peptides 14:1339–1378

Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167

Pollard GT, Howard JL (1990) Effects of drugs on punished behavior: pre-clinical test for anxiolytics. Pharmacol Ther 45:401–424

Reid LD (1985) Endogenous opioid peptides and regulation of drinking and feeding. Am J Clin Nutr 42:1099–1132

Reinhard Jr JF, Bannon MJ, Roth RH (1982) Acceleration by stress of dopamine synthesis and metabolism in prefrontal cortex: antagonism by diazepam. Naunyn-Schmiedeberg's Arch Pharmacol 318:374–377

Schaefer GJ (1988) Opiate antagonists and rewarding brain stimulation. Neurosci Biobehav Rev 12:1–17

Shephard RA (1986) Neurotransmitters, anxiety and benzodiazepines: a behavioral review. Neurosci Biobehav Rev 10:449–461

Spyraki C, Kazandjian A, Varonos D (1985) Diazepam-induced place preference conditioning: appetitive and antiaversive properties. Psychopharmacology 87:225–232

Soubrié P, Jobert A, Thiebot MH (1980) Differential effects of naloxone against the diazepam-induced release of behavior in rats in three aversive situations. Psychopharmacology 69:101–105

Stitzer ML, Griffiths RR, McLellan AT, Grabowski J, Hawthorne JW (1981) Diazepam use among methadone maintenance patients: patterns and dosages. Drug Alcohol Depend 8:189–199

Taylor DP, Riblet LA, Stanton HC, Eison AS, Eison MS, Temple Jr DL (1982) Dopamine and antianxiety activity. Pharmacol Biochem Behav 17 [Suppl. 1]:25–35

Tepperman FS, Hirst M, Smith P (1983) Brian and serum levels of naloxone following peripheral administration. Life Sci 33:1091–1096

Tokuyama S, Takahashi M, Kaneto H. (1989) Blockade of the development of analgesic tolerance to morphine by psychological stress through benzodiazepine receptor mediated mechanisms. Jpn J Pharmacol 51:425–427

Tripp G, McNaughton N (1987) Naloxone fails to block the effects of chlordiazepoxide on acquisition and performance of successive discrimination. Psychopharmacology 91:119–121

Tripp G, McNaughton N (1991) Naloxone and chlordiazepoxide: effects on acquisition and performance of signalled punishment. Pharmacol Biochem Behav 38:43–47

Vogel JR, Beer B, Clody DE (1971) A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21:1–7